UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Broadcom
AVGO
|
+$1.86B |
| 2 |
Prologis
PLD
|
+$1.82B |
| 3 |
Welltower
WELL
|
+$1.61B |
| 4 |
Microsoft
MSFT
|
+$1.53B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.35B |
Top Sells
| 1 |
Digital Realty Trust
DLR
|
+$822M |
| 2 |
AutoZone
AZO
|
+$481M |
| 3 |
Extra Space Storage
EXR
|
+$300M |
| 4 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$284M |
| 5 |
Meta Platforms (Facebook)
META
|
+$265M |
Sector Composition
| 1 | Technology | 35.15% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHV
1726
Schwab US Large-Cap Value ETF
SCHV
$15.7B
| $3.66M | ﹤0.01% |
119,878
+85,992
| +254% | +$2.68M |
|
1727
Donnelley Financial Solutions
DFIN
$1.13B
| $3.65M | ﹤0.01% |
77,421
+1,423
| +2% | +$69.8K |
|
1728
TriMas Corp
TRS
$1.45B
| $3.64M | ﹤0.01% |
101,362
+7,087
| +8% | +$254K |
|
1729
Intellia Therapeutics
NTLA
$1.82B
| $3.64M | ﹤0.01% |
283,958
+44,711
| +19% | +$570K |
|
1730
Newmark Group
NMRK
$2.68B
| $3.64M | ﹤0.01% |
242,571
-227,779
| -48% | -$3.59M |
|
1731
ACM Research
ACMR
$6.5B
| $3.63M | ﹤0.01% |
92,243
+6,327
| +7% | +$336K |
|
|
ARI
1732
Apollo Commercial Real Estate
ARI
$1.35B
| $3.62M | ﹤0.01% |
342,414
-35,059
| -9% | -$365K |
|
1733
Edgewise Therapeutics
EWTX
$4.44B
| $3.61M | ﹤0.01% |
114,720
+16,657
| +17% | +$480K |
|
1734
Photronics
PLAB
$1.68B
| $3.61M | ﹤0.01% |
89,415
+3,288
| +4% | +$119K |
|
1735
Universal Technical Institute
UTI
$2.65B
| $3.61M | ﹤0.01% |
99,976
+7,749
| +8% | +$245K |
|
1736
Ceco Environmental
CECO
$4.78B
| $3.59M | ﹤0.01% |
60,310
-5,027
| -8% | -$323K |
|
1737
RXO
RXO
$4.47B
| $3.59M | ﹤0.01% |
245,603
-31,056
| -11% | -$456K |
|
1738
Progyny
PGNY
$2.51B
| $3.58M | ﹤0.01% |
211,087
+19,285
| +10% | +$413K |
|
1739
Sonos
SONO
$1.79B
| $3.57M | ﹤0.01% |
266,400
-14,218
| -5% | -$215K |
|
1740
S&T Bancorp
STBA
$1.76B
| $3.55M | ﹤0.01% |
84,900
+3,167
| +4% | +$132K |
|
1741
ADMA Biologics
ADMA
$2.08B
| $3.55M | ﹤0.01% |
393,651
-6,368
| -2% | -$100K |
|
1742
First Bancorp
FBNC
$2.66B
| $3.55M | ﹤0.01% |
62,942
-2,317
| -4% | -$132K |
|
1743
Sally Beauty Holdings
SBH
$1.4B
| $3.54M | ﹤0.01% |
255,362
-7,746
| -3% | -$118K |
|
1744
Rapid7
RPD
$797M
| $3.53M | ﹤0.01% |
641,467
-772,485
| -55% | -$7.1M |
|
1745
Helios Technologies
HLIO
$2.63B
| $3.52M | ﹤0.01% |
54,409
+3,728
| +7% | +$250K |
|
1746
Northern Oil and Gas
NOG
$2.21B
| $3.52M | ﹤0.01% |
120,450
+16,494
| +16% | +$427K |
|
1747
Immunovant
IMVT
$7.95B
| $3.52M | ﹤0.01% |
141,728
+7,287
| +5% | +$189K |
|
1748
Blackbaud
BLKB
$1.43B
| $3.52M | ﹤0.01% |
91,089
+549
| +0.6% | +$27.4K |
|
1749
Celcuity
CELC
$5.06B
| $3.51M | ﹤0.01% |
30,795
+15,517
| +102% | +$1.69M |
|
1750
BioCryst Pharmaceuticals
BCRX
$2.52B
| $3.51M | ﹤0.01% |
368,978
-9,875
| -3% | -$76.7K |
|
Similar funds
